Robin Kramer - Mar 14, 2024 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Director
Signature
/s/ Robin Kramer
Stock symbol
ARMP
Transactions as of
Mar 14, 2024
Transactions value $
$0
Form type
4
Date filed
3/18/2024, 08:03 PM
Previous filing
Feb 21, 2024
Next filing
Dec 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award $0 +39.7K $0.00 39.7K Mar 14, 2024 Common Stock 39.7K $3.38 Direct F1
transaction ARMP Stock Options (Right to Buy) Award $0 +54.3K +137% $0.00 94K Mar 14, 2024 Common Stock 54.3K $3.38 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options shall vest upon the Company's 2024 annual shareholders meeting subject to the Non-Employee Director's continuous service through immediately prior to the convening of such meeting, with the date of grant being March 14, 2024.
F2 The Options shall vest (i) 50% on March 14, 2025 and (ii) 50% on March 14, 2026, in each case subject to continuous service through such vesting date.